These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12613525)

  • 1. Cytotoxic activity of T- and NK-cell lymphoma cells is not dependent on a mature cytotoxic phenotype.
    Boehrer S; Schui DK; Chow KU; Hoelzer D; Mitrou PS; Weidmann E
    Leuk Lymphoma; 2002 Dec; 43(12):2363-8. PubMed ID: 12613525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
    Chiang AK; Chan AC; Srivastava G; Ho FC
    Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes.
    Kumar S; Krenacs L; Medeiros J; Elenitoba-Johnson KS; Greiner TC; Sorbara L; Kingma DW; Raffeld M; Jaffe ES
    Hum Pathol; 1998 Apr; 29(4):397-403. PubMed ID: 9563791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules.
    Ohshima K; Haraoka S; Harada N; Kamimura T; Suzumiya J; Kanda M; Kawasaki C; Sugihara M; Kikuchi M
    Histopathology; 2000 Feb; 36(2):127-35. PubMed ID: 10672057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells.
    Katoh A; Ohshima K; Kanda M; Haraoka S; Sugihara M; Suzumiya J; Kawasaki C; Shimazaki K; Ikeda S; Kikuchi M
    Leuk Lymphoma; 2000 Sep; 39(1-2):97-111. PubMed ID: 10975388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
    J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas.
    Kamarashev J; Burg G; Mingari MC; Kempf W; Hofbauer G; Dummer R
    Am J Pathol; 2001 May; 158(5):1593-8. PubMed ID: 11337356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uniform expression of cytotoxic molecules in anaplastic large cell lymphoma of null/T cell phenotype and in cell lines derived from anaplastic large cell lymphoma.
    Foss HD; Demel G; Anagnostopoulos I; Araujo I; Hummel M; Stein H
    Pathobiology; 1997; 65(2):83-90. PubMed ID: 9253032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of perforin, granzyme A and TIA-1 by human uterine CD56+ NK cells implies they are activated and capable of effector functions.
    King A; Wooding P; Gardner L; Loke YW
    Hum Reprod; 1993 Dec; 8(12):2061-7. PubMed ID: 7512092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of cytotoxic molecules in CD8- and/or CD56-positive adult T-cell leukaemia/lymphoma.
    Ohshima K; Haraoka S; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Kikuchi M
    Virchows Arch; 1999 Aug; 435(2):101-4. PubMed ID: 10599307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types.
    Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M
    Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis.
    Cherin P; Herson S; Crevon MC; Hauw JJ; Cervera P; Galanaud P; Emilie D
    J Rheumatol; 1996 Jul; 23(7):1135-42. PubMed ID: 8823683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin.
    Krenacs L; Wellmann A; Sorbara L; Himmelmann AW; Bagdi E; Jaffe ES; Raffeld M
    Blood; 1997 Feb; 89(3):980-9. PubMed ID: 9028330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of granzyme B, perforin and TIA-1 in urine lymphocytes: noninvasive monitoring of renal transplant function.
    Barth C; Rodermann E; Stachowski J; Herzog R; Rohde S; Baldamus CA
    Transplant Proc; 1998 Aug; 30(5):2347. PubMed ID: 9723498
    [No Abstract]   [Full Text] [Related]  

  • 16. In situ detection of activated cytotoxic cells in follicular lymphomas.
    Leger-Ravet MB; Devergne O; Peuchmaur M; Solal-Celigny P; Brousse N; Gaulard P; Galanaud P; Emilie D
    Am J Pathol; 1994 Mar; 144(3):492-9. PubMed ID: 7510456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasopharyngeal/nasal type T/NK lymphomas: analysis of 14 cases and review of the literature.
    García-Cosío M; Santón A; Méndez MC; Rivas C; Martín C; Bellas C
    Tumori; 2003; 89(3):278-84. PubMed ID: 12908783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perforin and granzyme expression in cytotoxic T-cell lymphomas.
    Yamashita Y; Yatabe Y; Tsuzuki T; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
    Mod Pathol; 1998 Apr; 11(4):313-23. PubMed ID: 9578080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal CD8 positive cytotoxic T-cell lymphoma: a distinct clinicopathological entity.
    Mukai HY; Hasegawa Y; Kojima H; Okoshi Y; Takei N; Yamashita Y; Nagasawa T; Mori N
    Mod Pathol; 2002 Nov; 15(11):1131-9. PubMed ID: 12429791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells.
    Jacobs R; Hintzen G; Kemper A; Beul K; Kempf S; Behrens G; Sykora KW; Schmidt RE
    Eur J Immunol; 2001 Oct; 31(10):3121-7. PubMed ID: 11592089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.